Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02499770
Brief Title: Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC)

First Submitted : July 8, 2015
First Submitted that Met QC Criteria : July 15, 2015
First Posted : July 16, 2015 (Estimate)

Results First Submitted : May 22, 2020
Results First Submitted that Met QC Criteria : June 24, 2020
Results First Posted : July 9, 2020

Certification/Extension First Submitted : November 14, 2018
Certification/Extension First Submitted that Met QC Criteria : November 14, 2018
Certification/Extension First Posted : November 16, 2018

Last Update Submitted that Met QC Criteria : August 11, 2020
Last Update Posted : August 21, 2020